Creatv MicroTech, Inc. products

Personalized Cancer Therapy and Disease Monitoring: “Liquid biopsy” using circulating tumor cells (CTCs) is potentially a minimally invasive alternative to traditional tissue biopsy to determine cancer therapy. Enumeration of CTCs may be used to indicate prognosis and to monitor treatment. Isolation of CTCs by size exclusion is a widely researched technique to collect CTCs from patient peripheral blood. Creatv produces precision CellSieveTM microfilters with dense, uniform pores. Microfiltration using CellSieveTM takes only minutes and provides high capture efficiency.

Contains filters and buffers for 10 assays: For Research Use Only. This product is not intended for in vivo or diagnostic use. Performance, safety, and effectiveness have not been established and this kit is not approved by the FDA.